Results 91 to 100 of about 28,739 (249)

Walsh & Hoyt: Arteriovenous Malformations

open access: yes, 2005
Arteriovenous malformations (AVMs) are the most common form of intracranial vascular ...
Andrew Lee, MD
core  

Percutaneous embolization of arteriovenous malformations at the plantar aspect of the foot

open access: yes, 2015
Peripheral arteriovenous malformations (AVM) remain most challenging among various congenital vascular malformations to be treated. Here we present three illustrative patients with Yakes type IIIb and type IV AVM at the plantar aspect of the foot who ...
Baumgartner, Iris   +5 more
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation

open access: yes, 2006
Background and Purpose: The morbidity from spontaneous hemorrhage of untreated brain arteriovenous malformations (AVM) is not well described. Methods: The 241 consecutive AVM patients (mean age 3716 years, 52% women) from the prospective Columbia AVM ...

core  

Notch receptor expression in human brain arteriovenous malformations

open access: yes, 2015
The roles of the Notch pathway proteins in normal adult vascular physiology and the pathogenesis of brain arteriovenous malformations are not well-understood.
Hill-Felberg, S.   +3 more
core   +1 more source

Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1608-1618, July 2026.
ABSTRACT RASopathies are a group of genetic disorders caused by pathogenic variants in the RAS‐mitogen‐activated protein kinase (RAS–MAPK) signaling pathway, often presenting with congenital heart defects, craniofacial dysmorphisms, and developmental delays. To assess the diagnostic yield of genetic testing in patients with suspected RASopathies and to
Emanuele Bobbio   +16 more
wiley   +1 more source

Extracranial arteriovenous malformations: towards etiology-based therapeutic management

open access: yes
Anomalies during angiogenesis can initiate the formation of arteriovenous malformations (AVMs), characterized by aberrant connections between arteries and veins and fast lesional blood flow.
Boon, Laurence M.   +7 more
core   +1 more source

Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant bleeding disorder. The incidence of venous thromboembolisms among HHT patients is significantly greater than the general population. However, providing therapeutic anticoagulation in patients with an increased propensity for bleeding creates a clinical dilemma.
Christina Carfagnini, Manasa Kandula
wiley   +1 more source

Pseudotumor Cerebri Syndrome and Essential Thrombocythemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Pseudotumor cerebri syndrome (PTCS) is characterized by elevated intracranial pressure in the absence of intracranial mass lesions, structural abnormalities, or infectious conditions. Although the exact pathogenesis of PTCS remains largely elusive, it is increasingly recognized as a multifactorial condition.
Fang‐Tzu Chang   +2 more
wiley   +1 more source

Endovascular Treatment of Brain Arteriovenous Malformations in Siriraj Hospital

open access: yesSiriraj Medical Journal, 2020
Objective : To present our experience on endovascular embolization by using N-butyl cyanoacrylate and to demonstrate that this is an effective method in the treatment of brain arteriovenous malformations.
Anchalee Churojana   +4 more
doaj  

Home - About - Disclaimer - Privacy